Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hoogendoorn, T. Feenstra, R. Hoogenveen, M. Rutten-van Mölken (Rotterdam, Bilthoven, Groningen, Netherlands). Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD. Eur Respir J 2010; 36: Suppl. 54, 5145

Member's Comments

No comment yet.

Related content which might interest you: Effectiveness and cost-effectiveness of smoking cessation interventions Source: International Congress 2015 – New advances in smoking cessation interventions Year: 2015 The cost-effectiveness of antidepressants for smoking cessation in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 801s Year: 2006 Smoking cessation in COPD, modelling the cost effectiveness of minimal counseling or intensive counseling plus bupropion Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004 Cost-effectiveness of 5 smoking cessation interventions Source: Eur Respir J 2004; 24: Suppl. 48, 463s Year: 2004 Effectiveness of a specialised intervention for smoking cessation in hospitalised patients Source: Annual Congress 2007 - Smoking cessation Year: 2007 Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008 Smoking cessation compared to treatment of COPD and other smoking-related diseases using cost-effectiveness evidence Source: Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care Year: 2009 Evidence of the effectiveness and safety of first-line smoking cessation pharmacotherapy Source: Eur Respir Monogr 2021; 90: 97-117 Year: 2021 Comparison of efficacy of varenicline and nortriptyline– Short-term smoking cessation in outpatient setting Source: International Congress 2016 – Emerging issues in smoking cessation and tobacco products Year: 2016 Different types of medical intervention and the smoking cessation rate in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006 Effectiveness of varenicline as an aid to smoking cessation in primary care: An observational study Source: Annual Congress 2012 - Tobacco cessation Year: 2012 Efficacy and safety of bupropion for the treatment of smoking cessation in patients with chronic bronchitis Source: Eur Respir J 2004; 24: Suppl. 48, 503s Year: 2004 Cost effectiveness of retreatment with varenicline compared to other commonly used smoking cessation interventions Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards Year: 2015 Smoking cessation strategies in patients with COPD Source: Eur Respir J 2013; 41: 727-734 Year: 2013 Effectiveness of smoking cessation in patients with psychiatric disease Source: Annual Congress 2012 - Tobacco comorbidity Year: 2012 Effectiveness of varenicline treatment in a smoking cessation clinic Source: Annual Congress 2009 - Epidemiology of smoking and smoking cessation Year: 2009 Cost-effectiveness of a lung health intervention in US smokers Source: Annual Congress 2011 - Smoking-related diseases and smoking cessation Year: 2011 Efficacy of instant messages applications in smoking cessation in patients with COPD. Source: Virtual Congress 2021 – Digital health interventions in respiratory medicine Year: 2021 Long-term effectiveness of PEF-guided self-management in asthma Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007 The costs of smoking and the economics of smoking cessation Source: Eur Respir Mon; 2008: 42: 23–34 Year: 2008